** German healthcare group Fresenius' FREG.DE stock falls 4.0% in early Frankfurt trade after it reported fourth quarter adjusted operating profit and 2026 guidance below expectations
** The co reported for the fourth quarter an adjusted operating profit of 713.0 million euros ($841.63 million), below analysts' expectations that saw it at 714.8 million euros according to a poll by Vara research
** Fresenius also said it expects to grow in 2026 organically sales by 4-7%, the midpoint of which falls below analysts' expectations that see it at 5.9%
** It further expects its 2026 operating profit margin at around 11.5%, below analysts' expectations that sees it at 12.0%
** "Fresenius normally good for a positive surprise in earnings reports. But today´s results may not bring much upside," a local trader writes
** Fresenius' stock falls to the bottom of Germany's blue-chip index .GDAXI in early Frankfurt trade
** Up to Tueday's close the shares were up 2.82% YTD
($1 = 0.8472 euros)
(Reporting by Tristan Veyet)
((Tristan.veyet@thomsonreuters.com))